Real-time monitoring shows substantial excess all-cause mortality during second wave of COVID-19 in Europe, October to December 2020.
- Resource Type
- Academic Journal
- Authors
- Nørgaard SK; EuroMOMO hub, Statens Serum Institut, Copenhagen, Denmark.; Vestergaard LS; EuroMOMO hub, Statens Serum Institut, Copenhagen, Denmark.; Nielsen J; EuroMOMO hub, Statens Serum Institut, Copenhagen, Denmark.; Richter L; Austrian Agency for Health and Food Safety, Vienna, Austria.; Schmid D; Austrian Agency for Health and Food Safety, Vienna, Austria.; Bustos N; Sciensano, Brussels, Belgium.; Braye T; Sciensano, Brussels, Belgium.; Athanasiadou M; Ministry of Health, Nicosia, Cyprus.; Lytras T; European University Cyprus, Nicosia, Cyprus.; Denissov G; National Institute for Health Development, Tallinn, Estonia.; Veideman T; National Institute for Health Development, Tallinn, Estonia.; Luomala O; Finnish National Institute for Health and Welfare, Helsinki, Finland.; Möttönen T; Finnish National Institute for Health and Welfare, Helsinki, Finland.; Fouillet A; French Public Health Agency (Santé Publique France), Saint-Maurice, France.; Caserio-Schönemann C; French Public Health Agency (Santé Publique France), Saint-Maurice, France.; An der Heiden M; Robert Koch Institute, Berlin, Germany.; Uphoff H; Hessisches Landesprüfungs- und Untersuchungsamt im Gesundheitswesen, Dillenburg, Germany.; Gkolfinopoulou K; Hellenic Centre for Disease Control and Prevention, Athens, Greece.; Bobvos J; National Public Health Center, Budapest, Hungary.; Paldy A; National Public Health Center, Budapest, Hungary.; Rotem N; Health & Vital Statistics Sector, Central Bureau of Statistics, Jerusalem, Israel.; Kornilenko I; Health & Vital Statistics Sector, Central Bureau of Statistics, Jerusalem, Israel.; Domegan L; Health Service Executive - Health Protection Surveillance Centre, Dublin, Ireland.; O'Donnell J; Health Service Executive - Health Protection Surveillance Centre, Dublin, Ireland.; Donato F; Dipartimento Epidemiologia del SSR, Lazio - ASL Roma 1, Rome, Italy.; Scortichini M; Dipartimento Epidemiologia del SSR, Lazio - ASL Roma 1, Rome, Italy.; Hoffmann P; Health Directorate Luxembourg - Division de l'inspection sanitaire, Luxembourg, Luxembourg.; Velez T; Health Directorate Luxembourg - Division de l'inspection sanitaire, Luxembourg, Luxembourg.; England K; Directorate for Health Information and Research, Pieta, Malta.; Calleja N; Directorate for Health Information and Research, Pieta, Malta.; van Asten L; National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands.; Stoeldraijer L; Statistics Netherlands, The Hague, the Netherlands.; White RA; Norwegian Institute of Public Health, Oslo, Norway.; Paulsen TH; Norwegian Institute of Public Health, Oslo, Norway.; da Silva SP; Instituto Nacional de Saúde Doutor Ricardo Jorge, Lisboa, Portugal.; Rodrigues AP; Instituto Nacional de Saúde Doutor Ricardo Jorge, Lisboa, Portugal.; Klepac P; National Institute of Public Health, Ljubljana, Slovenia.; Zaletel M; National Institute of Public Health, Ljubljana, Slovenia.; Fafangel M; National Institute of Public Health, Ljubljana, Slovenia.; Larrauri A; National Centre of Epidemiology, CIBER Epidemiología y Salud Pública (CIBERESP), Carlos III Health Institute, Madrid, Spain.; León I; National Centre of Epidemiology, CIBER Epidemiología y Salud Pública (CIBERESP), Carlos III Health Institute, Madrid, Spain.; Farah A; Public Health Agency of Sweden, Stockholm, Sweden.; Galanis I; Public Health Agency of Sweden, Stockholm, Sweden.; Junker C; Federal Statistical Office, Neuchâtel, Switzerland.; Perisa D; Federal Office of Public Health, Bern, Switzerland.; Sinnathamby M; Public Health England, Colindale, United Kingdom of Great Britain and Northern Ireland.; Andrews N; Public Health England, Colindale, United Kingdom of Great Britain and Northern Ireland.; O'Doherty MG; Public Health Agency, Northern Ireland, United Kingdom of Great Britain and Northern Ireland.; Irwin D; Public Health Agency, Northern Ireland, United Kingdom of Great Britain and Northern Ireland.; Kennedy S; Public Health Scotland, Glasgow, United Kingdom of Great Britain and Northern Ireland.; McMenamin J; Public Health Scotland, Glasgow, United Kingdom of Great Britain and Northern Ireland.; Adlhoch C; European Centre for Disease Prevention and Control, Solna, Sweden.; Bundle N; European Centre for Disease Prevention and Control, Solna, Sweden.; Penttinen P; European Centre for Disease Prevention and Control, Solna, Sweden.; Pukkila J; World Health Organization, Regional Office for Europe, Copenhagen, Denmark.; Pebody R; World Health Organization, Regional Office for Europe, Copenhagen, Denmark.; Krause TG; EuroMOMO hub, Statens Serum Institut, Copenhagen, Denmark.; Mølbak K; EuroMOMO hub, Statens Serum Institut, Copenhagen, Denmark.; Department of Veterinary and Animal Science, Faculty of Health and Medical Science, University of Copenhagen, Copenhagen, Denmark.
- Source
- Publisher: European Centre for Disease Prevention and Control (ECDC) Country of Publication: Sweden NLM ID: 100887452 Publication Model: Print Cited Medium: Internet ISSN: 1560-7917 (Electronic) Linking ISSN: 1025496X NLM ISO Abbreviation: Euro Surveill Subsets: MEDLINE
- Subject
- Language
- English
The European monitoring of excess mortality for public health action (EuroMOMO) network monitors weekly excess all-cause mortality in 27 European countries or subnational areas. During the first wave of the coronavirus disease (COVID-19) pandemic in Europe in spring 2020, several countries experienced extraordinarily high levels of excess mortality. Europe is currently seeing another upsurge in COVID-19 cases, and EuroMOMO is again witnessing a substantial excess all-cause mortality attributable to COVID-19.